New cell therapy tested for Tough-to-Treat blood cancer
NCT ID NCT05886491
First seen Oct 31, 2025 · Last updated Apr 07, 2026 · Updated 28 times
Summary
This early-stage study tested a new cell therapy called GDX012 for adults with acute myeloid leukemia (AML) that has returned or not responded to other treatments. The main goals were to find the safest dose and see how well patients tolerated the treatment. The trial was designed to enroll about 53 participants but was stopped early after 16 people took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Comprehensive Cancer Center of Northwestern University
Chicago, Illinois, 60611, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
National Cancer Center Hospital East
Kashiwa, 277-8577, Japan
-
Sarah Cannon/CBCI
Denver, Colorado, 80218, United States
-
Thomas Jefferson University
New York, New York, 10065, United States
-
Tri-Star BMT/Sarah Cannon Nashville
Nashville, Tennessee, 37203, United States
-
University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama, 35205, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.